Top compounds associated with response to SPATC1L


Feature Type Standardized
Nominal ANOVA
mRNA Bexarotene CTRPv2 pan-cancer AAC 0.044 0.2
mRNA semagacestat CTRPv2 pan-cancer AAC -0.045 0.2
mRNA SR8278 CTRPv2 pan-cancer AAC 0.15 0.2
mRNA MST-312 CTRPv2 pan-cancer AAC 0.042 0.2
mRNA paclitaxel CCLE pan-cancer AAC 0.053 0.3
mRNA AZD0530 CCLE pan-cancer AAC 0.056 0.3
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.061 0.3
mRNA AZD4547 CTRPv2 pan-cancer AAC 0.045 0.3
mRNA hyperforin CTRPv2 pan-cancer AAC 0.046 0.3
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.04 0.3
Download CSV